MDB-66. HIGH-THROUGHPUT SMALL MOLECULE DRUG SCREENING, TRANSCRIPTOMICS AND INTEGRATIVE AI IDENTIFY TARGETABLE MYC-DEPENDENT THERAPEUTIC VULNERABILITIES IN HIGH-RISK MEDULLOBLASTOMA

Authors: Gemma Llargués-Sistac, Louisa Taylor, Janet Lindsey, Marie Claire Buttigieg, Alaide Morcavallo, Chantelle Bowers, Harvey Che, Colin Kwok, Daniel Williamson, John Anderson, Laura K Donovan, Rebecca M Hill, Bissan Al-Lazikani, Louis Chesler, Steven C Clifford

Published: 2024-06-18

DOI: 10.1093/neuonc/noae064.515

Source: Full article

MDB-66. HIGH-THROUGHPUT SMALL MOLECULE DRUG SCREENING, TRANSCRIPTOMICS AND INTEGRATIVE AI IDENTIFY TARGETABLE MYC-DEPENDENT THERAPEUTIC VULNERABILITIES IN HIGH-RISK MEDULLOBLASTOMA

Abstract